Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)
5.58
+0.22 (4.10%)
Apr 10, 2026, 10:20 AM CST
SHE:300239 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 745.31 | 850.21 | 970.41 | 937.89 | 609.82 |
Other Revenue | - | 34.72 | 4.1 | 5.51 | 2.34 |
| 745.31 | 884.93 | 974.51 | 943.4 | 612.17 | |
Revenue Growth (YoY) | -15.78% | -9.19% | 3.30% | 54.11% | 36.39% |
Cost of Revenue | 571.24 | 687.88 | 728.53 | 712.28 | 515.98 |
Gross Profit | 174.07 | 197.06 | 245.98 | 231.12 | 96.19 |
Selling, General & Admin | 70.2 | 67.96 | 69.75 | 67.81 | 40.1 |
Research & Development | 25.48 | 27.36 | 26.1 | 25.83 | 12.98 |
Other Operating Expenses | -1.53 | 4.92 | 12.58 | 12.52 | 9.23 |
Operating Expenses | 94.15 | 99.82 | 110.21 | 106.47 | 62.34 |
Operating Income | 79.92 | 97.23 | 135.77 | 124.65 | 33.85 |
Interest Expense | - | -2.56 | -5.14 | -7.63 | -4.78 |
Interest & Investment Income | - | 7.11 | 6.37 | 4.84 | 2.88 |
Currency Exchange Gain (Loss) | - | 1.03 | 0.26 | 0.7 | -0.03 |
Other Non Operating Income (Expenses) | 0.08 | -0.18 | -0.17 | -0.21 | 1.44 |
EBT Excluding Unusual Items | 80 | 102.63 | 137.08 | 122.35 | 33.37 |
Gain (Loss) on Sale of Investments | -2.86 | -3.74 | -4.33 | -1.91 | -2.53 |
Gain (Loss) on Sale of Assets | -0.09 | -0.28 | 0.08 | 0.14 | 0.09 |
Asset Writedown | -15.13 | -0.88 | -0.86 | -0.42 | -0.6 |
Other Unusual Items | - | 7.79 | 12.47 | 11.25 | 11.21 |
Pretax Income | 61.92 | 105.63 | 144.49 | 131.65 | 41.54 |
Income Tax Expense | 7.58 | 14.37 | 17.12 | 16.21 | 5.72 |
Earnings From Continuing Operations | 54.34 | 91.26 | 127.37 | 115.44 | 35.82 |
Minority Interest in Earnings | 0 | -5.28 | -7.49 | -6 | 0.66 |
Net Income | 54.34 | 85.98 | 119.89 | 109.44 | 36.48 |
Net Income to Common | 54.34 | 85.98 | 119.89 | 109.44 | 36.48 |
Net Income Growth | -36.80% | -28.28% | 9.55% | 199.96% | 97.74% |
Shares Outstanding (Basic) | 586 | 594 | 593 | 593 | 564 |
Shares Outstanding (Diluted) | 626 | 647 | 612 | 593 | 564 |
Shares Change (YoY) | -3.24% | 5.72% | 3.12% | 5.25% | 7.89% |
EPS (Basic) | 0.09 | 0.14 | 0.20 | 0.18 | 0.06 |
EPS (Diluted) | 0.09 | 0.13 | 0.20 | 0.18 | 0.06 |
EPS Growth | -34.69% | -32.16% | 6.24% | 185.01% | 83.29% |
Free Cash Flow | 26.65 | -8.04 | 67.15 | 86.76 | 0.15 |
Free Cash Flow Per Share | 0.04 | -0.01 | 0.11 | 0.15 | - |
Dividend Per Share | - | 0.025 | 0.022 | 0.026 | 0.006 |
Dividend Growth | - | 13.64% | -15.38% | 333.33% | - |
Gross Margin | 23.36% | 22.27% | 25.24% | 24.50% | 15.71% |
Operating Margin | 10.72% | 10.99% | 13.93% | 13.21% | 5.53% |
Profit Margin | 7.29% | 9.72% | 12.30% | 11.60% | 5.96% |
Free Cash Flow Margin | 3.58% | -0.91% | 6.89% | 9.20% | 0.02% |
EBITDA | 177.18 | 183.56 | 217.73 | 210.16 | 89.17 |
EBITDA Margin | 23.77% | 20.74% | 22.34% | 22.28% | 14.57% |
D&A For EBITDA | 97.26 | 86.32 | 81.96 | 85.52 | 55.32 |
EBIT | 79.92 | 97.23 | 135.77 | 124.65 | 33.85 |
EBIT Margin | 10.72% | 10.99% | 13.93% | 13.21% | 5.53% |
Effective Tax Rate | 12.25% | 13.60% | 11.85% | 12.31% | 13.76% |
Revenue as Reported | - | 884.93 | 974.51 | 943.4 | 612.17 |
Advertising Expenses | - | 0.57 | 1.12 | 1.08 | 0.81 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.